Exhuberance Over Exubera
- Pamela F. Hite,
- Ann M. Barnes and
- Philip E. Johnston, PharmD
Abstract
IN BRIEF
The isolation, purification, and clinical use of insulin has been enhanced many times in the past 80 years. This article outlines the development of insulin and describes the formulation, activity, and practical use of a newly approved inhaled form of insulin sold under the trade name Exubera.
Footnotes
-
Pamela F. Hite is a 2006 PharmD candidate at Samford University McWhorter School of Pharmacy in Birmingham, Ala. Ann M. Barnes is a 2006 PharmD candidate at the University of Mississippi College of Pharmacy in Oxford, Miss. Philip E. Johnston, PharmD, is the assistant director of the Department of Pharmacy at Vanderbilt University Medical Center in Nashville, Tenn.
- American Diabetes Association
